|
Day One, Tuesday, 1 April 2008
|
8.30am | Registration and welcome coffee
|
8.50am | Opening remarks and welcome from the Chair |
| | Mr Warren Todd, Executive Director, International Disease Management Alliance
|
| CDM- A GLOBAL PERSPECTIVE |
|
9am | International keynote address:
Addressing the worldwide crisis of chronic disease
• Trends in chronic disease growth and expenditure
• Forces driving an increase in chronic disease
• International developments and innovative measures |
| | Mr Warren Todd, Executive Director, International Disease Management Alliance
|
9.30am | Keynote address:
Taking a unified tact in implementing CDM in Australia
• A stepwise and collaborative approach
• Embracing the population-based methodology
• Integrating “systemness” across the continuum of care |
| |
|
10am | DM experts panel session:
Overcoming the key factors which preclude effective CDM
• How and why CDM has failed in the past
• Today’s obstacles and enablers to profitable CDM
• Success stories from the global market |
| | Mr Al Lewis, Executive Director, Disease Management Purchasing Consortium International
|
10.45am | Morning tea and Speed Networking
|
| THE GOVERNMENT’S CDM MANDATE |
|
11.30am | NSW Health Department address:
The Government’s role in integrating the sectors
• Reducing costs by encouraging collaborative involvement
• Addressing conflict between the State and Federal systems
• Government expectations for the Broader Health Policy
• Future initiatives to streamline CDM |
| |
|
11.55am | Panel session:
Moving forward: what’s required of the key stakeholders?
• What the Government has done and still needs to do
• Interfacing with the private sector
• Facilitating clinicians’ efforts at the coalface |
| | Dr Suhan Baskar, Director Hospital at Home Project, Sydney Adventist Hospital Dr Andrew Boyden, National Director - Clinical Issues, National Heart Foundation
|
| THE BUSINESS CASE FOR CDM |
|
12.40pm | International keynote address:
Learning lessons from market leaders
• The micro and macro business case for CDM: why would anyone do it and why should everyone do it?
• Savings vs. earnings for investment outlays
• The evolution from Disease Management to Health Management |
| |
|
1.05pm | Networking lunch
|
2.05pm | International keynote address:
From ROIs to VOIs: new methods of assessing investments
• Overcoming problems associated with measuring accurately
• Efficacy vs. efficiency
• Factoring time frames into predictive modelling |
| | Mr Al Lewis, Executive Director, Disease Management Purchasing Consortium International
|
2.35pm | Case study:
Examining the value of CDM programs in Australia
• Clinical results and projected ROIs
• Co-ordinating efforts across the sectors
• Training patients to become independent |
| |
|
3pm | Panel discussion:
Adapting American systems for the Australian landscape
• Translating an established system to fit a local market
• Crucial differences to consider in Australia’s health system
• Learning to operate effectively in a different environment |
| | Ms Fiona Lynch, Program Manager Health Development Unit, Medibank Private
|
3.45pm | Afternoon tea
|
| PARTNERSHIPS AND ALLIANCES |
|
4.15pm | Opportunities for private providers: assessing and embracing
• The private service potential in the new legislative setting
• Shifting the service profile
• Integrating services to promote collaboration |
| |
|
4.40pm | Executive panel session:
Managing a multi-provider environment
• Avoiding a 2-tiered healthcare system
• Co-ordinating efforts across the public and private sectors
• Addressing conflicting drivers between the two systems |
| | Ms Mary Foley, Chief Executive Officer, St Vincents and Mater Health Dr Tony Joseph, Director of Emergency Services, Royal North Shore Public Hospital
|
5.30pm | End of Day One and networking cocktail party
|
|
Day Two, Wednesday, 2 April 2008
|
8.30am | Arrival and welcome coffee
|
8.50am | Opening remarks and welcome from the Chair |
| | Mr Warren Todd, Executive Director, International Disease Management Alliance
|
9am | Consumer panel session:
The Voice of the Patients forum
Real life patients share their experiences about what has worked, what hasn’t and what needs to be changed in the approach to CDM. |
| |
|
| LEVERAGING TECHNOLOGY FOR BETTER CDM |
|
9.30am | The impact of technology on healthcare delivery
• Inefficiencies of traditional records-management
• Time frames involved in the e-Health revolution
• Communicating between the public and private sectors
• Protecting privacy while accessing patient data |
| |
|
9.55am | Case study:
Enabling e-Health transformation: The Chronic Disease Management Network
• Why aren’t existing ICT approaches working?
• Changing the current paradigm to surmount the obstacles
• Generating health and business opportunities |
| |
|
10.20am | The future of remote patient monitoring
• Empowering patients to support self-care
• Measurement precision as a means of reducing medical errors
• Facilitating clinical pathways
• Overcoming the barriers to RPM reform |
| |
|
10.50am | Morning tea
|
| ENGAGING THE EMPLOYERS |
|
11.20am | Examining the financial impact of CD in the workforce
• Cost of absenteeism and presenteeism to Australian business
• Growth of the Australian corporate health field
• Comparing international corporate health measures |
| |
|
11.45am | Reducing the cost of CD by working with employers
• The potential scope for employer CDM programs
• Business case: outlays vs. returns
• Measuring improvements in productivity |
| |
|
12.10pm | Case study:
A CDM corporate success story
• Strategy development: partnering with private insurance and providers
• Implementation costs and financial returns
• What worked, what didn’t and what more needs to be done? |
| |
|
12.35pm | Networking Lunch
|
| PHARMACEUTICALS IN CDM |
|
1.35pm | Maximising the value of medicine by targeting non-compliance
• Repercussions of non-compliance on health costs
• Barriers to medication adherence
• Solutions to minimise non-compliance |
| |
|
2pm | Case study:
Examining the value of Quality Use of Medicines Programs
• Successful strategies to increase compliance
• Clinical results of patient assistance programs
• Including QUM in CDM |
| |
|
2.25pm | Panel session:
Reducing healthcare costs by aligning compliance initiatives
• Using adherence monitoring technology to improve compliance
• Incorporating compliance drivers into CDM
• Involving pharmacists in monitoring compliance |
| |
|
3.10pm | Afternoon tea
|
| THE FUTURE |
|
3.40pm | Roundtable discussions
Discussion 1: Incorporating ‘Wellness’ in the present to control chronic disease in the future
Dr Emad Rizk, President, McKesson (USA)
Discussion 2: The science of motivating patients to maximise results
Leanne Wells, Policy and Development Manager, Australian General Practice Network
Discussion 3: Coordinating co-morbidities
Assoc Prof Malcolm Battersby, Director, Flinders Human Behaviour and Human Research Unit
|
4.30pm | Panel discussion:
The future of CDM
• Main challenges being faced in Australia today
• Global strategies for the international market
• Market opportunities for key stakeholders
• Financial projections for CDM in the future |
| | Mr Al Lewis, Executive Director, Disease Management Purchasing Consortium International
|
5pm | Closing remarks and close of conference
|
